Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Imatinib Mesylate × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Burkitt Lymphoma 2 Uveal Melanoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Neoplasms 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Melanoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Biphenotypic, Acute 1 Gastrointestinal Stromal Tumors 1 Desmoid Tumors 1 Dermatofibrosarcoma 1 Chordoma 1 Carcinoma, Adenoid Cystic 1 Blast Crisis 1

Interventions

Specimen Handling 4 Nivolumab 4 Biopsy 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Immunoglobulin G 2 Bevacizumab 2 talimogene laherparepvec 1 sargramostim 1 regorafenib 1 prednylidene 1 deltacortene 1 decitabine and cedazuridine drug combination 1 avelumab 1 atezolizumab 1 aflibercept 1 X-Rays 1 Sirolimus 1 Radiosurgery 1 Prednisone 1 Paclitaxel 1 NEO212 1 MAPRE1 protein, human 1 Lidocaine, Prilocaine Drug Combination 1 IFL protocol 1 Disulfides 1 Cyclophosphamide 1 Colony-Stimulating Factors 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡